GlassScriptPhysician profile
Jeegar A Jailwala
NPI 1821053471
$1,139.42
in general payments reported to CMS, 2019-2025
6 companies · $92.76 in 2025
The $92.76 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.39 · 2020: $28.00 · 2021: $287 · 2022: $239 · 2023: $276 · 2024: $140 · 2025: $92.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $608.51 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $338.24 | 2021-2024 | Entyvio, Gattex |
| Boston Scientific Corporation | $146.85 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $16.89 | 2024 | Rebyota |
| Cook Medical LLC | $15.39 | 2019 | |
| Olympus America INC. | $13.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeegar Jailwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.